Dr. Nealanjon P. Das , DO
Internal Medicine - Nephrology โข Newark, DE
4923 Ogletown Stanton Rd Ste 200
Newark, DE 197132081
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Nealanjon Das is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on September 13, 2006; this date does not establish years in practice.
-
Published CMS data list 3,925 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q5106 โ Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units: 1,230 service units.
- 99232 โ Subsequent hospital care with moderate levelof medical decision making: 648 service units.
- 99233 โ Subsequent hospital care with moderate levelof medical decision making: 371 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,481 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Amlodipine Besylate โ 139 prescription fills, including refills.
- Lisinopril โ 123 prescription fills, including refills.
- Losartan Potassium โ 109 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 39 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 36 clinicians with data). Median for this group: 2,852. Middle half: 1,454 to 4,053.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,744 in 2020 to 3,925 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
4923 Ogletown Stanton Rd Ste 200
Newark, DE 197132081
NPPES lists 1 additional practice-address record in Elkton, MD. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Nephrology Associates Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
At Still University Of Health Sciences, College Of Osteo Med, Kirksville
2001
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
774 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $333,945 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $261,365 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
3,873 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$317,862 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,173.58 across 54 records.
By nature of payment
- Food and Beverage: $1,173.58 across 54 records.
Reporting-company totals (3 largest of 19)
- Amgen Inc.: $172.56 across 9 records.
- Otsuka America Pharmaceutical, Inc.: $112.51 across 5 records.
- Fresenius USA Marketing, Inc.: $107.09 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Das has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Das as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Newark and Delaware
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 36 clinicians with data). Median for this group: 2,852. Middle half: 1,454 to 4,053.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $233,255. Middle half: $151,849 to $320,315.
A higher Medicare-allowed amount than 80% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 36 clinicians with data). Median for this group: $226,539. Middle half: $182,506 to $322,303.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $180,676. Middle half: $116,220 to $249,891.
A higher Medicare payment amount than 80% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 36 clinicians with data). Median for this group: $176,763. Middle half: $141,555 to $250,970.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 819. Middle half: 428 to 1,158.
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: 855. Middle half: 490 to 1,152.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $80,962. Middle half: $53,704 to $266,466.
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: $169,273. Middle half: $51,169 to $313,653.
22 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Newark, DE (50 in Delaware).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Newark
63.6% of these 22 clinicians have the CMS telehealth indicator.
77.3% of these 22 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 32% from 5,744 in 2020 to 3,925 in 2024.
- 2020: 5,744
- 2021: 6,502
- 2022: 5,648
- 2023: 4,901
- 2024: 3,925
-
Medicare-allowed amount
Medicare-allowed amount increased 11% from $300,259 in 2020 to $333,945 in 2024.
- 2020: $300,259
- 2021: $351,632
- 2022: $342,334
- 2023: $347,818
- 2024: $333,945
-
Paid by Medicare
Paid by Medicare increased 10% from $236,581 in 2020 to $261,365 in 2024.
- 2020: $236,581
- 2021: $277,861
- 2022: $268,988
- 2023: $272,620
- 2024: $261,365
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 81% from 817 in 2020 to 1,481 in 2024.
- 2020: 817
- 2021: 947
- 2022: 1,245
- 2023: 1,598
- 2024: 1,481
-
30-day fills
30-day fills increased 89% from 2,044 in 2020 to 3,873 in 2024.
- 2020: 2,044
- 2021: 2,483
- 2022: 3,295
- 2023: 4,114
- 2024: 3,873
-
Part D drug cost
Part D drug cost decreased 32% from $467,030 in 2020 to $317,862 in 2024.
- 2020: $467,030
- 2021: $85,748
- 2022: $204,262
- 2023: $346,760
- 2024: $317,862
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $585.90 in 2021 to $1,173.58 in 2025.
- 2021: $585.90
- 2022: $702.43
- 2023: $1,258.62
- 2024: $1,216.86
- 2025: $1,173.58
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 54 records totaling $1,173.58.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $38.20 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $30.55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $29.50 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $28.89 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $28.20 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $27.82 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $27.81 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $27.72 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $26.57 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $26.33 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $25.99 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $25.87 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
VOYXACT | General | $25.61 |
| KYOWA KIRIN, INC. |
Food and Beverage
In-kind items and services
|
CRYSVITA | General | $24.63 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $24.63 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $23.65 |
| AKEBIA THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
Vafseo | General | $23.49 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $23.21 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
GATTEX | General | $23.17 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $22.56 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $22.40 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $22.11 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $22.09 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $21.53 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $21.36 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q5106
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
|
1,230 | 37 | $10.00 | $7.31 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
648 | 246 | $97.96 | $76.59 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
371 | 138 | $131.00 | $114.97 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
351 | 254 | $20.00 | $16.03 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
260 | 43 | $660.00 | $344.13 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
259 | 196 | $120.00 | $85.03 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
196 | 155 | $170.00 | $99.34 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
138 | 130 | $210.00 | $126.95 |
|
99291
Critical care, first 30-74 minutes
|
99 | 38 | $380.00 | $206.58 |
|
90966
Home dialysis services per month (20 years or older)
|
84 | 11 | $660.00 | $285.95 |
|
90935
Hemodialysis procedure with physician evaluation
|
77 | 50 | $325.00 | $68.34 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
64 | 62 | $260.00 | $166.03 |
|
96372
Injection of drug or substance under skin or into muscle
|
59 | 36 | $30.00 | $14.02 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
46 | 21 | $604.00 | $285.03 |
|
90945
Dialysis procedure including 1 evaluation
|
32 | 14 | $325.00 | $82.45 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
11 | 11 | $235.00 | $147.31 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 139 | 12,096 | $1,497.00 | 47 |
| Lisinopril | Lisinopril | 123 | 10,075 | $1,258.51 | 40 |
| Losartan Potassium | Losartan Potassium | 109 | 9,860 | $1,429.28 | 39 |
| Furosemide | Furosemide | 86 | 7,066 | $377.26 | 38 |
| Calcitriol | Calcitriol | 77 | 6,480 | $2,614.07 | 27 |
| Spironolactone | Spironolactone | 74 | 6,490 | $946.02 | 26 |
| Allopurinol | Allopurinol | 69 | 6,086 | $824.36 | 25 |
| Chlorthalidone | Chlorthalidone | 66 | 5,748 | $1,040.69 | 22 |
| Carvedilol | Carvedilol | 64 | 5,450 | $699.20 | 20 |
| Jardiance | Empagliflozin | 57 | 3,750 | $72,838.83 | 14 |
| Tamsulosin Hcl | Tamsulosin Hcl | 49 | 4,410 | $845.19 | 18 |
| Ozempic | Semaglutide | 48 | 1,644 | $52,497.93 | โ |
| Hydralazine Hcl | Hydralazine Hcl | 46 | 4,020 | $1,429.53 | 16 |
| Farxiga | Dapagliflozin Propanediol | 36 | 3,120 | $54,227.01 | 14 |
| Potassium Chloride | Potassium Chloride | 28 | 2,330 | $1,147.87 | โ |
| Nifedipine Er | Nifedipine | 26 | 2,247 | $1,352.36 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 25 | 2,250 | $528.29 | โ |
| Ondansetron Odt | Ondansetron | 25 | 224 | $1,010.36 | โ |
| Lokelma | Sodium Zirconium Cyclosilicate | 25 | 1,217 | $27,712.94 | โ |
| Hydrochlorothiazide | Hydrochlorothiazide | 24 | 2,123 | $199.15 | โ |
| Rybelsus | Semaglutide | 24 | 930 | $28,258.18 | โ |
| Potassium Citrate Er | Potassium Citrate | 22 | 1,946 | $3,168.84 | โ |
| Atorvastatin Calcium | Atorvastatin Calcium | 20 | 1,800 | $479.53 | โ |
| Glimepiride | Glimepiride | 19 | 990 | $295.95 | โ |
| Omeprazole | Omeprazole | 17 | 1,170 | $105.29 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-06-24NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20170120000022
DE
5597949883
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Nephrology Associates Pa
137 W High St, Elkton, MD 219218614
Phone: 4106209200
Nephrology Associates Pa
4923 Ogletown Stanton Rd, Newark, DE 197132081
Phone: 3022250451
Secondary Practice Locations
137 W High St Ste 1a
Elkton, MD 219218614
Phone: 4106209200
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Additional practice office at 137 W High St Ste 1A, Elkton, MD 219218614
Registered at 4923 OGLETOWN STANTON RD STE 200, NEWARK, DE 197132081 (Tel: 3022250451)
Registered at 4923 OGLETOWN STANTON RD STE 200, NEWARK, DE 197132081 (Tel: 3022250451)
Internal Medicine (license number reported to NPPES: DE C2-0011770)
Registered at 4755 OGLETOWN STANTON RD, CHRISTIANA HOSPITAL, SUITE 5A43, NEWARK, DE 19718 (Tel: 3026230188)
Internal Medicine (license number reported to NPPES: VA 0102201483)
NPI status registered as active in NPPES database
Registered at 4755 OGLETOWN STANTON RD, CHRISTIANA HOSPITAL, SUITE 5A43, NEWARK, DE 197182200 (Tel: 3026230188)
Registered at 200 HYGEIA DR, CCHS PHYSICIAN CONTRACTING, SUITE 2300, NEWARK, DE 197132049
Recorded as NEALANJON DAS, DO
Internal Medicine (license number reported to NPPES: VA 0102201483)
NPI status registered as active in NPPES database
Registered at 4755 OGLETOWN STANTON RD, CHRISTIANA HOSPITAL, SUITE 5A43, NEWARK, DE 197182200 (Tel: 3026230188)
Registered at 200 HYGEIA DR, CCHS PHYSICIAN CONTRACTING, SUITE 2300, NEWARK, DE 197132049
Recorded as NEALANJON DAS, DO
Internal Medicine (license number reported to NPPES: DE C2-0011770)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Newark
- Dr. Liann Abu Salman, MD
- Dr. Jeffrey Cicone, MD
- Dr. Lindsey Slater, MD
- Dr. Monarch Shah, MD
- Dr. Prerna Sharma, MD
- Dr. James Torain, MD
Mailing Address
4923 Ogletown Stanton Rd Ste 200
Newark, DE 197132081
Phone: 3022250451